Top Market Shifts Transforming the Quantum-Enhanced Predictive Genomics Market Landscape: Key Insights

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Quantum-Enhanced Predictive Genomics Market Through 2025?
The market size for quantum-enhanced predictive genomics has experienced rapid expansion in the past few years. The market is projected to increase from $1.45 billion in 2024 to $1.95 billion in 2025, displaying a compound annual growth rate (CAGR) of 34.1%. This historic growth is largely due to factors such as a growing interest in precision medicine, the increasing complexity of genomic data, larger investments in quantum computing, wider applicability in disease prediction, and flourishing partnerships between the technology and healthcare industries.

What's the Projected Size of the Global Quantum-Enhanced Predictive Genomics Market by 2029?
The market size of quantum-enhanced predictive genomics is predicted to skyrocket in the following years, expanding to a value of $6.26 billion by 2029 with a compound annual growth rate (CAGR) of 33.8%. This anticipated growth on the forecast horizon is driven by factors such as the surge in personalized healthcare adoption, increasing merger of AI into quantum genomics, intensified emphasis on early detection of diseases, escalating governmental and private R&D investments, and improved access to sophisticated genomic datasets. Upcoming trends in the forecast period encompass advancements in quantum machine learning models, innovations in genomic data encryption and security, the merging of multi-omics with quantum analytics, the creation of cloud-based quantum genomics platforms, and partnerships between quantum tech enterprises and biotech firms.

View the full report here:
https://www.thebusinessresearchcompany.com/report/quantum-enhanced-predictive-genomics-global-market-report

Top Growth Drivers in the Quantum-Enhanced Predictive Genomics Industry: What's Accelerating the Market?
The quantum-enhanced predictive genomics market is projected to expand due to the increasing need for personalized medicine. Personalized medicine involves creating medical treatments that are precisely formulated according to an individual's genetic, biological, and clinical characteristics. This rising trend towards more bespoke therapies is attributed to an improvement in effectiveness, with the creation of treatments that align with an individual's genetics resulting in enhanced outcomes and fewer negative impacts. Quantum-enhanced predictive genomics further that cause of personalised medicine by making it possible to analyze complicated genomic data at an ultra-fast pace, and thus enabling medical professionals to devise highly accurate and individualized plans for treatment and prevention. For example, NHS England, a public health system in the UK, reported that in 2024, the NHS genomic medicine service conducted more than 810,000 tailored genomic tests for patients, a rise that represented an 8% increase from 2023. This clearly illustrates the escalating clinical demand for care, influenced by genomics. This is why the growing need for personalized medicine is projected to be a key factor propelling the growth of the quantum-enhanced predictive genomics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28308&type=smp

What Trends Will Shape the Quantum-Enhanced Predictive Genomics Market Through 2029 and Beyond?
Significant players in the quantum-enhanced predictive genomics industry are prioritizing innovative strategies such as high-throughput genomic data processing. This approach expedites the discovery of genetic variances, augments predictive accuracy in bespoke medicine, and bolsters quicker, more precise scrutiny of intricate genomic datasets. High-throughput genomic data processing is a swift, broad-scale examination of genomic sequences executed via sophisticated computational techniques. For example, in June 2025, Norma Group, located in Germany and renowned for manufacturing engineered and standardized joining and fluid-handling technology, allied with Seoul National University Bundang Hospital (SNUBH) to implement quantum algorithms in extensive genomic examination. This project targets augmenting the recognition of genetic alterations utilizing quantum-enhanced combinatorial optimization, boosting both the pace and precision of genomic data handling beyond traditional computing techniques. Key implementations involve precision diagnosis, personalized treatment scheming, and genetic susceptibility evaluation for diseases such as cancer and neurological conditions.

What Are the Main Segments in the Quantum-Enhanced Predictive Genomics Market?
The quantum-enhanced predictive genomics market covered in this report is segmented as

1) By Technology: Quantum Computing, Quantum Machine Learning, Quantum Cryptography, Other Technologies
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Disease Risk Assessment, Drug Discovery, Personalized Medicine, Genomic Data Analysis, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Research Institutes, Healthcare Providers, Other End-Users

Subsegments:
1) By Quantum Computing: Gate Based Quantum Computing, Quantum Annealing, Topological Quantum Computing, Photonic Quantum Computing
2) By Quantum Machine Learning: Supervised Learning, Unsupervised Learning, Reinforcement Learning, Deep Learning
3) By Quantum Cryptography: Quantum Key Distribution, Quantum Random Number Generation, Quantum Secure Communication, Post Quantum Cryptography
4) By Other Technologies: Quantum Sensors, Quantum Simulation, Quantum Networking, Hybrid Quantum Classical Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28308&type=smp

Which Top Companies are Driving Growth in the Quantum-Enhanced Predictive Genomics Market?
Major companies operating in the quantum-enhanced predictive genomics market are Google LLC, Microsoft Corporation, Alibaba Group Holding Limited, Amazon Web Services Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, accenture* plc, IBM Corporation, Pfizer Inc., Bayer AG, AstraZeneca plc, GlaxoSmithKline plc, Honeywell International Inc., Fujitsu Limited, Eviden, Xanadu Quantum Technologies Inc., Pasqal SA, Rigetti Computing Inc., IonQ Inc., D-Wave Systems Inc.

Which Regions Will Dominate the Quantum-Enhanced Predictive Genomics Market Through 2029?
North America was the largest region in the quantum-enhanced predictive genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in quantum-enhanced predictive genomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28308

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.